Etna, NH, United States of America

Roy H Pang

This inventor holds 26 USPTO granted patents, primarily in Morphogen Research. Top assignees: Creative Biomolecules, Inc., Stryker Corporation, A. Menarini S.a.s.. Active years: 1991-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roy H Pang. Retrieved from https://idiyas.com/inventor/roy-h-pang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 15

Forward Citations = 668(Granted Patents)


Location History:

  • Medway, MA (US) (1991 - 1999)
  • Etna, NH (US) (1997 - 2000)

Company Filing History:


Years Active: 1991-2000

Loading Chart...
Areas of Expertise:
Morphogen Treatment
Tissue Regeneration
Osteogenic Proteins
Morphogenic Protein
Ischemia-Reperfusion
Gastrointestinal Ulcers
Bone Mass
Protein Analogues
Chondrogenic Protein
Bioadhesive
Thrombus Conjugates
Nucleic Acids
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roy H. Pang in Biologics

Introduction

Roy H. Pang, based in Etna, NH, is a distinguished inventor known for his significant contributions in the field of biomedicine. With a remarkable portfolio of 26 patents, he has paved the way for advancements in tissue morphogenesis and organ transplantation.

Latest Patents

Among his latest patents, Roy H. Pang has introduced groundbreaking innovations, including the OP-3 induced morphogenesis. This patent discloses nucleic acid and amino acid sequences for a novel morphogenic protein. Additionally, it outlines methods for producing and expressing the protein in a biologically active form, while also detailing techniques to utilize the protein for tissue morphogenesis in mammals. These methods aim to enhance progenitor cell populations, stimulate differentiation, and promote tissue-specific growth. Another notable patent focuses on morphogen treatment of organ implants, presenting methods and compositions that enhance the viability of transplanted organs and tissues, ensuring protection from potential damage.

Career Highlights

Throughout his career, Roy H. Pang has been associated with prominent organizations such as Creative Biomolecules, Inc. and Stryker Corporation. His work in these companies has facilitated the application of his innovative ideas into practical solutions that address critical challenges in medicine.

Collaborations

Roy has collaborated with esteemed colleagues, including Hermann Oppermann and Thangavel Kuberasampath. These partnerships have further enriched his research and innovation endeavors, contributing to the development of effective medical treatments and technologies.

Conclusion

Roy H. Pang continues to impact the scientific community with his inventive spirit and dedication to improving human health through innovative biological solutions. His extensive patent portfolio reflects a commitment to advancing medical science, establishing him as a prominent figure in the field of biomedical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…